Lilly opens biotech in San Diego
82,514 sq ft facility to host up to 15 biotech companies, fueling the development of next-generation medicines
82,514 sq ft facility to host up to 15 biotech companies, fueling the development of next-generation medicines
The association called for an end to the constant issuance of regulatory circulars that make operations unpredictable and capital-intensive.
Bayer Co.Lab AdVenture platform will accelerate biotech innovation through global investment networks
Includes new $1.2 billion investment in manufacturing facilities, AI and advanced digital technologies, creating hundreds of highly skilled U.S. jobs
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
Launches National IVD validation portal and protocols; highlights India’s strengthening health research ecosystem
AHLL will become a 100% subsidiary of AHEL with 99.42% held by AHEL and balance in the ESOP pool
NouvNeu001 is the world’s first allogeneic iPSC-derived cell therapy for Parkinson’s disease to receive this designation
Program provides access to Lilly-trained artificial intelligence to help accelerate breakthrough medicines
Subscribe To Our Newsletter & Stay Updated